Latest Malaysia News

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

Lynas Rare Earths has deepened its footprint in Southeast Asia with a strategic A$50 million investment in JS Link’s new magnet factory in Malaysia, aiming to capture growth in automotive and renewable sectors.

Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.

ReNerve Limited has secured regulatory approval to market its flagship NervAlign Nerve Cuff in Indonesia, marking a major step in its Asia-Pacific expansion and unlocking access to one of the region’s largest nerve repair markets.

Altech Batteries has sold its non-core land in Meckering, Western Australia, for $950,000, boosting working capital while retaining mining rights. The sale also triggered a $500,000 bank guarantee tied to €2 million bearer bonds due in October.

Hastings Technology Metals has secured a $1 million strategic placement from Malaco Mining to bolster its rare earth projects in Australia and Thailand, enhancing balance sheet flexibility and downstream processing ambitions.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.

Ovanti Limited has inked a four-year exclusive partnership with Yuno.trade, positioning itself as the payment processor and technology backbone for a new licensed prediction market platform targeting Southeast and Central Asia.

ReNerve Limited has appointed UG Medical to distribute its NervAlign nerve repair products in Malaysia, tapping into a fast-growing healthcare market backed by government investment.

Bridge SaaS Limited (ASX: BGE) is issuing nearly 20 million Loyalty Options to reward shareholders, exercisable at $0.03 and expiring in 2031, aiming to bolster future capital without immediate dilution.

TruScreen Group reported a 42% increase in FY2026 sales driven by new market entries including India and Indonesia, alongside launching a large-scale cervical cancer screening program in Vietnam and submitting major UNITAID proposals.

Trajan Group Holdings reports steady market demand and successful cost initiatives in H2 FY26 but warns of a $4 million revenue hit from Australian dollar appreciation.